Short sellers increased positions sharply through April even as analysts trimmed targets. Options sentiment flipped bullish ahead of Monday's report.
Short interest in XYL hit 5.85 million shares as of April 23, representing 2.40% of free float. That marks a 22% climb over the past month and a 6% rise in the past week. Days to cover stands at 2.38 based on the most recent FINRA data. Cost to borrow dropped 25% over the past week to 0.37%, suggesting ample supply despite the position build. Utilisation rose to 3.2%, near the 52-week high of 3.77% set just two days earlier on April 21.
The put/call ratio collapsed to 0.25 on April 24, well below the 20-day mean of 0.64. The z-score of -1.61 signals a pronounced skew toward call buying. PCR touched a 52-week low of 0.20 on April 21 before ticking up slightly. The shift from bearish to bullish positioning occurred abruptly in mid-April as the ratio had hovered near 0.77 throughout late March.
Wall Street maintains a buy rating with 10 buy recommendations and 9 hold ratings. The mean price target of $154 implies 27% upside from the current $121.46. UBS downgraded the stock from Buy to Neutral on April 21 and cut its target to $132 from $152. JP Morgan lowered its target to $160 from $170 on April 16 while maintaining Overweight. Stifel trimmed its price objective to $163 from $175 on April 14, keeping a Buy rating. Oppenheimer and Jefferies also reduced targets in late March and early April.
The P/E ratio of 21.5 is down slightly over the past month despite the stock's 0.8% gain. EV/EBITDA of 14.2 ticked lower by 2% over 30 days. The stock ranks in the 78th percentile on forward EPS growth and the 62nd percentile on earnings surprise. Dividend quality scores in the 98th percentile. Momentum, quality, and value ML scores were unavailable.
Insiders sold $3.77 million net over the past 90 days across multiple executives in early March tax-related transactions. Vanguard added 953,000 shares in Q1 to hold 12.4% of shares outstanding. BlackRock increased its stake by 464,000 shares to 10.4%. State Street added 280,000 shares to reach 4.6%.
Xylem last reported on February 10. The stock has printed earnings four times since late 2025.
No active ORTEX Alpha signals.
See the live data behind this article on ORTEX.
Open XYL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
